J
Jason Wang
Researcher at University of California, Los Angeles
Publications - 23
Citations - 770
Jason Wang is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Brachytherapy & Prostate cancer. The author has an hindex of 11, co-authored 23 publications receiving 683 citations. Previous affiliations of Jason Wang include UCLA Health.
Papers
More filters
Journal ArticleDOI
Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials
Christopher R. King,Debra Freeman,Irving D. Kaplan,Donald B. Fuller,Giampaolo Bolzicco,Sean P. Collins,Robert J. Meier,Jason Wang,Patrick A. Kupelian,Michael L. Steinberg,Alan W. Katz +10 more
TL;DR: PSA relapse-free survival rates after SBRT compare favorably with other definitive treatments for low and intermediate risk patients, and the current evidence supports consideration of S BRT among the therapeutic options for these patients.
Journal ArticleDOI
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
Steven Shoptaw,Steven Shoptaw,Keith G. Heinzerling,Erin Rotheram-Fuller,Trevor Steward,Jason Wang,Aimee-Noelle Swanson,Richard De La Garza,Thomas F. Newton,Walter Ling +9 more
TL;DR: Bupropion was no more effective than placebo in reducing MA use in planned analyses, though bupropion did reduce cigarette smoking.
Journal ArticleDOI
Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
TL;DR: In the setting of SBRT, an elevated pretreatment NLR, PLR, and neutrophil count and the presence of lymphocytopenia independently predicted for poor OS.
Journal ArticleDOI
Focal high-dose-rate brachytherapy: A dosimetric comparison of hemigland vs. conventional whole-gland treatment
Mitchell Kamrava,Melody P. Chung,Oluwatosin Kayode,Jason Wang,Leonard S. Marks,Patrick A. Kupelian,Michael L. Steinberg,Sang-June Park,D. Jeffrey Demanes +8 more
TL;DR: The good dosimetry results obtained in this study support the feasibility of HG brachytherapy by using a subset of the WG catheter array and provide complete target coverage with a catheter arrays designed for WG coverage.
Journal ArticleDOI
From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis
Robyn Banerjee,Sang-June Park,Erik S. Anderson,D. Jeffrey Demanes,Jason Wang,Mitchell Kamrava +5 more
TL;DR: The magnitude of the reductions achievable with treating progressively smaller sub-volumes suggests the potential to reduce morbidity, but the clinical impact on morbidity and tumor control remain to be investigated.